MRI-targeted prostate biopsy: a review of technique and results (scientific article)

Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy Cohort

Q29037865

Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group

Q30054617

Real-time Virtual Sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data

Q33679272

Ultrasound for prostate imaging and biopsy

Q34330269

Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients.

Q34346871

Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging

Q35354750

Comparison of pelvic phased-array versus endorectal coil magnetic resonance imaging at 3 Tesla for local staging of prostate cancer

Q35932176

Active surveillance for low-risk prostate cancer

Q36141777

How good is MRI at detecting and characterising cancer within the prostate?

Q36536899

Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy

Q37052521

Prostate cancer risk inflation as a consequence of image-targeted biopsy of the prostate: a computer simulation study

Q37587129

Guided e-MRI prostate biopsy can solve the discordance between Gleason score biopsy and radical prostatectomy pathology

Q37736890

Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting

Q37825030

Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding--multiparametric MR imaging for detection and biopsy planning

Q37828322

MR-compatible assistance system for biopsy in a high-field-strength system: initial results in patients with suspicious prostate lesions

Q37848583

Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer

Q37866554

Detection and localization of prostate cancer with the targeted biopsy strategy based on ADC map: a prospective large-scale cohort study

Q37975995

Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review

Q38022388

Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study

Q38098361

Prostate MRI: who, when, and how? Report from a UK consensus meeting

Q38119283

The Clinical Value of Performing an MRI before Prostate Biopsy

Q38263045

Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

Q39278530

The value of endorectal MR imaging to predict positive biopsies in clinically intermediate-risk prostate cancer patients

Q39559674

Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy

Q39678593

Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients

Q39685186

Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience

Q39727835

Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer

Q39793890

Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner

Q39816598

Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy

Q39895770

Potential of (1)H MR spectroscopic imaging to segregate patients who are likely to show malignancy of the peripheral zone of the prostate on biopsy.

Q39901755

Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies

Q39944232

Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer

Q39998299

Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy.

Q40004173

Magnetic resonance imaging targeted biopsy in men with previously negative prostate biopsy results

Q40009557

Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer

Q40106756

MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results

Q42472195

Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy.

Q43197140

Do additional cores from MRI cancer-suspicious lesions to systematic 12-core transrectal prostate biopsy give better cancer detection?

Q43905409

Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours

Q44623612

A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion

Q45389556

Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.

Q45967722

Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.

Q46644825

Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system

Q46778616

Using biopsy to detect prostate cancer.

Q48453091

Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device.

Q51279329

Morphologic, functional, and metabolic magnetic resonance imaging-guided prostate biopsy in a patient with prior negative transrectal ultrasound-guided biopsies and persistently elevated prostate-specific antigen levels.

Q53476916

T2-weighted MR imaging of prostate cancer: multishot echo-planar imaging vs fast spin-echo imaging.

Q53640094

Accuracy of MRI/MRSI-based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy

Q56987516

Magnetic resonance image-guided biopsies with a high detection rate of prostate cancer

Q58915161

Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection

Q63966218

Dynamic Contrast-enhanced–magnetic Resonance Imaging Evaluation of Intraprostatic Prostate Cancer: Correlation with Radical Prostatectomy Specimens

Q63966229

Is it possible to model the risk of malignancy of focal abnormalities found at prostate multiparametric MRI?

Q63966470

Incidental prostatic carcinoma detected by MRI and diagnosed by MRI/CT-guided biopsy

Q68792783

Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study

Q73007017

Detection of prostate cancer by magnetic resonance imaging and spectroscopy in vivo

Q73725652

Combination of signal intensity measurements of lesions in the peripheral zone of prostate with MRI and serum PSA level for differentiating benign disease from prostate cancer

Q73761807

Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectal coil MR imaging

Q79197210

Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy

Q79613182

Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10

Q80072940

3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; Initial experience(1)

Q80405902

MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results

Q80534791

Diagnostic accuracy of MRI/MRSI for patients with persistently high PSA levels and negative TRUS-guided biopsy results

Q80822796

Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study

Q80841761

Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study

Q81643644

Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen

Q82228462

Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers

Q83423979

MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy

Q83932123

Evaluation of a structured report of functional prostate magnetic resonance imaging in patients with suspicion for prostate cancer or under active surveillance

Q84326224

Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: a cohort study

Q84435616

Prostate cancer detection using an extended prostate biopsy schema in combination with additional targeted cores from suspicious images in conventional and functional endorectal magnetic resonance imaging of the prostate

Q84559983

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

biopsy

Q179991

P304

page(s)

589-597

P577

publication date

2013-09-24

P1433

published in

Nature Reviews Urology

Q2079265

P1476

title

MRI-targeted prostate biopsy: a review of technique and results

P478

volume

Reverse relations

cites work (P2860)

Q50315275	18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies
Q50243071	Can we deliver randomized trials of focal therapy in prostate cancer?
Q95261047	Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naïve biopsy patients
Q41643652	Development and Phantom Validation of a 3-D-Ultrasound-Guided System for Targeting MRI-Visible Lesions During Transrectal Prostate Biopsy
Q41988350	Diagnostic Accuracy of Robot-Guided, Software Based Transperineal MRI/TRUS Fusion Biopsy of the Prostate in a High Risk Population of Previously Biopsy Negative Men.
Q50890262	Evaluation of the 'Prostate Interdisciplinary Communication and Mapping Algorithm for Biopsy and Pathology' (PIC-MABP).
Q35678391	Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error.
Q92167564	Integration of spatial information in convolutional neural networks for automatic segmentation of intraoperative transrectal ultrasound images
Q36449937	Investigating the ability of multiparametric MRI to exclude significant prostate cancer prior to transperineal biopsy
Q94335582	MRI pathway and TRUS‐guided biopsy for detecting clinically significant prostate cancer
Q92672901	Machine learning classifiers can predict Gleason pattern 4 prostate cancer with greater accuracy than experienced radiologists
Q37055000	Magnetic Resonance Imaging-Ultrasound Fusion-Guided Prostate Biopsy: Review of Technology, Techniques, and Outcomes
Q64912571	Optimal biopsy strategy for prostate cancer detection by performing a Bayesian network meta-analysis of randomized controlled trials.
Q57780524	PET/MRI and prostate cancer
Q39178750	Pathologic correlation of transperineal in-bore 3-Tesla magnetic resonance imaging-guided prostate biopsy samples with radical prostatectomy specimen
Q50182743	Performance of 68Ga-PSMA PET/CT for Prostate Cancer Management at Initial Staging and Time of Biochemical Recurrence
Q35244433	Prognostic Utility of PET in Prostate Cancer.
Q50960499	Prostate interdisciplinary communication and mapping algorithm for biopsy and pathology (PIC-MABP) of multiparametric MRI findings.
Q38218443	Random biopsy: when, how many and where to take the cores?
Q38321884	Recent advances in image-guided targeted prostate biopsy.
Q58112714	The applied research of simultaneous image acquisition of T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) in the assessment of patients with prostate cancer
Q38825859	The impact of African American race on prostate cancer detection on repeat prostate biopsy in a veteran population
Q96135129	The role of MRI/TRUS fusion biopsy in the diagnosis of clinically significant prostate cancer
Q35100748	Transperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study
Q53727657	[Ultrasonography of the prostate gland : From B‑image through multiparametric ultrasound to targeted biopsy].